Actively Recruiting
HYPNOsis in the Management of Atopic Dermatitis in Children and Teenagers
Led by Centre Hospitalier Universitaire de la Réunion · Updated on 2025-09-12
32
Participants Needed
1
Research Sites
172 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Atopic dermatitis (AD) is a chronic inflammatory dermatosis, common in children. It causes pruritus and skin lesions that can have a significant impact on patients' quality of life. AD can be difficult to treat because of its chronicity, demanding local care, corticophobia and the financial cost of non-reimbursed products. Patients are often looking for therapeutic alternatives. Medical hypnosis is a therapeutic alternative via hypnoanalgesia induced by direct suggestions of comfort and skin soothing and via anxiolysis, by working on stress management and self-esteem reinforcement. Four studies are interested in its action in AD and seem to show a reduction in pruritus, skin pain, an improvement in the intensity of atopic dermatitis, sleep, mood and for some a cure of AD. These results are encouraging but limited by the absence of a control group or by the small population included. Therefore, we propose in a first step to evaluate the feasibility of an hypnosis program through a pilot study, designed in the miniature format of a future, larger scale, randomized controlled trial.
CONDITIONS
Official Title
HYPNOsis in the Management of Atopic Dermatitis in Children and Teenagers
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Children aged 8 to 17 years
- Understanding French
- Clinical diagnosis of mild-to-severe atopic dermatitis with SCORing Atopic Dermatitis (SCORAD)
- Referred by their physician to the Reunionese therapeutic education program for atopic dermatitis at Reunion University Hospital
- Oral consent of the child and one legal representative collected
You will not qualify if you...
- Children refusing to participate in the hypnosis sessions
- Unable to listen to audio files
- Already practicing self-hypnosis for atopic dermatitis before inclusion
- Having contraindications to hypnosis such as psychiatric disorders or psychosis
- Receiving systemic treatment for atopic dermatitis
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CHU de la Réunion
Saint-Denis, Reunion, 97400
Actively Recruiting
Research Team
J
Juliette MIQUEL, MD
CONTACT
C
Camille ESPAGNON, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here